SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-111219
Filing Date
2024-12-20
Accepted
2024-12-20 16:30:57
Documents
15
Period of Report
2024-12-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225494-8k_renalytix.htm   iXBRL 8-K 68978
2 PRESS RELEASE ea022549401ex99-1_renalytix.htm EX-99.1 18700
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3858
  Complete submission text file 0001213900-24-111219.txt   273375

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnlx-20241219.xsd EX-101.SCH 3033
5 XBRL LABEL FILE rnlx-20241219_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rnlx-20241219_pre.xml EX-101.PRE 22371
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0225494-8k_renalytix_htm.xml XML 3411
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 241568406
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)